GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » Revenue

CanadaBis Capital (TSXV:CANB) Revenue : C$20.91 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital Revenue?

CanadaBis Capital's revenue for the three months ended in Jan. 2024 was C$4.31 Mil. Its revenue for the trailing twelve months (TTM) ended in Jan. 2024 was C$20.91 Mil. CanadaBis Capital's Revenue per Share for the three months ended in Jan. 2024 was C$0.03. Its Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.15.

During the past 12 months, the average Revenue per Share Growth Rate of CanadaBis Capital was 12.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 66.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 8 years, CanadaBis Capital's highest 3-Year average Revenue per Share Growth Rate was 66.70% per year. The lowest was 66.70% per year. And the median was 66.70% per year.


CanadaBis Capital Revenue Historical Data

The historical data trend for CanadaBis Capital's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital Revenue Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
Revenue
Get a 7-Day Free Trial - 4.43 6.87 11.67 22.22

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.22 6.05 4.81 5.74 4.31

Competitive Comparison of CanadaBis Capital's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Revenue distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Revenue falls into.



CanadaBis Capital Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$20.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


CanadaBis Capital Revenue Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines

From GuruFocus